Nkarta to Participate in March Investor Conferences
Provided By GlobeNewswire
Last update: Feb 25, 2025
SOUTH SAN FRANCISCO, Calif., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a biopharmaceutical company developing engineered natural killer (NK) cell therapies, today announced its participation in the following investor conferences:
Read more at globenewswire.com
